Joseph S. Podolski
Keine laufenden Positionen mehr
Profil
Joseph S.
Podolski served as the President, Chief Executive Officer & Director of Repros Therapeutics, Inc. from 1992 to 2017.
He also worked as a Director at Oncolix, Inc. and held Principal positions at Abbott Laboratories, G.D.
Searle & Co., Inc., and Baxter Pharmaceuticals, Inc. Podolski received his undergraduate and graduate degrees from the Illinois Institute of Technology.
Ehemalige bekannte Positionen von Joseph S. Podolski
| Unternehmen | Position | Ende |
|---|---|---|
| REPROS THERAPEUTICS INC | Chief Executive Officer | 01.02.2017 |
Oncolix, Inc. /Old/
 Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Director/Board Member | 01.01.2017 |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Baxter Pharmaceuticals, Inc.
 Baxter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Baxter Pharmaceuticals, Inc. offers a diverse range of generic injectable medicines, including oncology drugs and premixed anti-infectives, analgesics, and critical care medicines. The American company is the only company to provide all three commonly used modern inhaled anesthetics for general anesthesia. Baxter has expanded its pharmaceuticals portfolio through acquisitions, partnerships, and internal development programs to improve access to essential medications and advance pharmacy efficiency and patient care. | Corporate Officer/Principal | - |
Ausbildung von Joseph S. Podolski
| Illinois Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Oncolix, Inc. /Old/
Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Health Technology |
Baxter Pharmaceuticals, Inc.
Baxter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Baxter Pharmaceuticals, Inc. offers a diverse range of generic injectable medicines, including oncology drugs and premixed anti-infectives, analgesics, and critical care medicines. The American company is the only company to provide all three commonly used modern inhaled anesthetics for general anesthesia. Baxter has expanded its pharmaceuticals portfolio through acquisitions, partnerships, and internal development programs to improve access to essential medications and advance pharmacy efficiency and patient care. | Health Technology |
